Communiqués Seegene, Inc.

Actions

A096530

KR7096530001

Recherche biotechnologique et médicale

Cours en clôture Korea S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
35 450,00 ^KRW	+5,19%		+4,26%	+48,95%

07/08	Seegene, Inc. publie ses résultats financiers pour le premier semestre clos le 30 juin 2026	CI
27/07	Seegene Inc. annonce une approche globale de tests PCR syndromiques pour les infections de l'appareil reproducteur	CI

Communiqués

27/07	Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)	AQ
15/07	Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing	AQ
08/07	Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards	AQ
20/04	Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows	AQ
05/12	/C O R R E C T I O N -- Seegene Inc./	AQ
05/12	Seegene Establishes French Subsidiary to Expand European Footprint	AQ
02/09/25	Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants	AQ
05/08/25	Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics	AQ
23/07/25	Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025	AQ
01/07/25	Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics	AQ
02/05/25	Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation	AQ
09/04/25	Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation	AQ
28/10/24	/C O R R E C T I O N -- Seegene Inc./	AQ
24/10/24	Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative	AQ
08/10/24	Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative	AQ
09/09/24	Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1	AQ
03/09/24	Seegene and Springer Nature Launch Nature Awards MDx Impact Grants, to Innovate Syndromic PCR Diagnostic Assays	AQ
02/09/24	Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays	AQ
26/08/24	Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration	AQ
05/08/24	Seegene Showcased its Multiplex Technology at ADLM 2024	AQ
16/07/24	Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024	AQ
16/05/24	Seegene and Springer Nature Announce Strategic Alliance	AQ
09/04/24	Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'	AQ
08/04/24	Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"	AQ
15/03/24	Seegene and Springer Nature Announce Awardees for the Open Innovation Program	AQ